These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34856508)

  • 21. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
    Tefferi A; Skoda R; Vardiman JW
    Nat Rev Clin Oncol; 2009 Nov; 6(11):627-37. PubMed ID: 19806146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
    Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
    Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating
    Umrau K; Naganuma K; Gao Q; Dogan A; Kizaki M; Roshal M; Liu Y; Yabe M
    Leuk Lymphoma; 2023 Jan; 64(1):238-241. PubMed ID: 36308018
    [No Abstract]   [Full Text] [Related]  

  • 24. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypereosinophilia associated with dysplastic features and a constitutional translocation previously not described.
    Hermida G; Manjón R; Rodríguez-Salazar M; Calasanz MJ
    Haematologica; 2000 Sep; 85(9):997-8. PubMed ID: 10980647
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic Eosinophilic Leukaemia Associated with JAK2 Exon 13 Insertion/Deletion Mutations.
    Lafferty N; Salmon M; Cross NCP; Singer I; Cooney A; Jayaprakash R
    Acta Haematol; 2022; 145(2):201-206. PubMed ID: 34515041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
    Cervera N; Itzykson R; Coppin E; Prebet T; Murati A; Legall S; Vey N; Solary E; Birnbaum D; Gelsi-Boyer V
    Am J Hematol; 2014 Jun; 89(6):604-9. PubMed ID: 24595958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
    Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
    Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.
    Steensma DP; Dewald GW; Lasho TL; Powell HL; McClure RF; Levine RL; Gilliland DG; Tefferi A
    Blood; 2005 Aug; 106(4):1207-9. PubMed ID: 15860661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
    Liu YC; Illar GM; Bailey NG
    J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia.
    Ma X; Wen L; Wu L; Wang Q; Yao H; Wang Q; Ma L; Chen S
    Cancer Genet; 2015; 208(1-2):52-3. PubMed ID: 25749351
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.
    Macdonald D; Cross NC
    Pathobiology; 2007; 74(2):81-8. PubMed ID: 17587879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.
    Baumeister J; Chatain N; Sofias AM; Lammers T; Koschmieder S
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.
    Gotlib J
    Acta Haematol; 2005; 114(1):7-25. PubMed ID: 15995322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
    Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
    Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular bases of leukemia, MPD and MDS].
    Kitamura T
    Rinsho Ketsueki; 2009 Mar; 50(3):174-81. PubMed ID: 19352084
    [No Abstract]   [Full Text] [Related]  

  • 37. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of serum Sialyl-Lewis(x) antigen levels in acute leukemias, myelodysplastic syndromes, myeloproliferative disorders and malignant lymphomas.
    Takubo T; Shibata H; Terada Y; Aoyama Y; Nakamae H; Yamamura R; Shima E; Makita K; Tanaka K; Ohta K; Yamane T; Hino M; Hashimoto S; Kamitani T; Tatsumi N
    Leuk Lymphoma; 2002 Sep; 43(9):1889-91. PubMed ID: 12685851
    [No Abstract]   [Full Text] [Related]  

  • 39. Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients.
    Buradkar A; Bezerra E; Coltro G; Lasho TL; Finke CM; Gangat N; Carr RM; Binder M; Mangaonkar AA; Ketterling R; Khan S; Rodriguez V; Tefferi A; Patnaik MM
    Leukemia; 2021 Feb; 35(2):644-649. PubMed ID: 32513965
    [No Abstract]   [Full Text] [Related]  

  • 40. The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.
    Yip SF; So CC; Chan AY; Liu HY; Wan TsK; Chan LC
    Leukemia; 2006 Jun; 20(6):1165. PubMed ID: 16572200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.